Close Menu

NIAID

The software firm will use NGS data from patient biopsies to create molecular profiles and offer individualized cancer treatment recommendations.

Its most advanced gene expression signatures are for infectious disease diagnostics and are aimed at enabling the appropriate prescription of antiviral and antibiotic medications.

A new analysis finds that better grant-writing skills may help early-career researchers stay funded and stay in academia.

The company said it will use the funding to accelerate the development of an affordable sequencing test for metagenomic samples.

The new centers will generate genomic resources and tools for infectious disease research.

In PLOS this week: hierarchical fine-mapping approach, genomic and sub-genomic variations in lab porcine epidemic diarrhea virus strains, and more.

First Stages

Early trial of experimental gene-based Zika vaccine indicates it is tolerated and leads to an antibody response.

The grant is specifically intended to support the development of noninvasive, rapid tests that can be used at the point of care in developing country settings.

An exome sequencing analysis of individuals from eight families led to homozygous loss-of-function mutations in CD55 and ties to complement system activity.

After identifying mutations in CARD11 in individuals with severe atopic dermatitis, investigators began untangling potential signaling consequences.

Pages

Forensic genetic firm Verogen has bought the genetic genealogy site GEDmatch.

Researchers have 3D-printed plastic bunnies that encase the information needed to make more such bunnies in DNA, according to Discover magazine.

Dan Rather, the former CBS Evening News anchor and executive producer of a new documentary, writes at the Guardian that everyone needs to know about CRISPR.

In PNAS this week: analysis of FOXA1 upregulation in ER-positive breast cancer, gene editing to correct recessive dystrophic epidermolysis bullosa, and more.